chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After withdrawing the needle after injection,  blood spurted from injection site, significant enough to puddle on the floor. I applied light pressure with a cotton ball and once the bleeding had stopped, a knot had already formed at the injection site. Pt reported no other symptoms and was monitored in store for 15 minutes to verify no other symptoms arose.
Information has been received from a certified medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, drug allergies and concomitant medications were not reported. On 29-JUN-2016, the patient inadvertently received a dose of GARDASIL, lot# K011492, expiration date: 22-JUN-2016 (expired product administered), dose unknown, intramuscularly. No adverse effects were reported. Additional information has been requested.
Pateint visited Emergency Department on 11 May 2005 complaining of rash behind arm and behind knee. Patient thought it was a reaction to Smallpox vaccination received on 20 Apr 2005.
Pt. very nervous - on exam table in mom's arms. CBC done by finger stick, MENACTRA administered IM to (L) deltoid. Pt. became very pale/ashy. Pt. then became unconscious in mom's arms. Eyes rolled to back of head, pt. then had seizure-like episode. Entire body jerking and shaking. Lasted approx 5-8 seconds. Pt. was groggy and crying when came to. Also lethargic, c/o nausea and numbness to (L) side of body. B/P - 115/80. Gave popsicle and crackers. Let pt. rest - took approx 45 minutes for pt. to recover/get up. Sent home with mom.
Patient is a 70 y.o. female with past medical history of obesity, hypertension, dyslipidemia, chronic diastolic heart failure, paroxysmal AFib not on anticoagulation, GERD, type 1 diabetes complicated by gastroparesis and peripheral neuropathy, immunosuppression 2/2 kidney and pancreas transplant, PAD w/ left transmetatarsal amputation and right above the knee amputation, history of CVA, depression, anxiety, iron-deficiency anemia, who presents for evaluation of dyspnea.   Tested positive for COVID 19 on 11/14.   Admitted on 11/17/22
Information has been received from a physician concerning a female patient with no pertinent medical history and no known drug allergies who on 14-JAN-2003 was vaccinated with a dose of RECOMBIVAX HB (lot# not provided) 0.5ml intramuscularly. There was no concomitant medication. On 13-MAR-2003 patient received a dose of COMVAX (lot# not provided). On 20-MAY-2003 patient received a second dose of COMVAX (lot# not provided) and on 28-JUL-2003 patient received a third dose of COMVAX (lot# not provided). Patient is a non-responder after getting 4 doses of hepatitis b vaccine. Patient sought medical attention via an office visit. "Non-responder status from a hepatitis tilter from the last few days". At the time of this report patient had not yet recovered. Additional information has been requested.
Heart palpitations 3 days after vaccination, culminating in a diagnosed influenza vaccine myocarditis on Nov. 18.  Continue to suffer from random heart beat skips as of this writing. The medical records state sinus arrest, chills, headache, myalgia, chest pain, SOB, and dizziness.
devel redness & swelling @ site of inject rt deltoid; seen @ MD 15OCT93; upper rt arm swollen red;
Information has been received from a certified medical assistant concerning a patient who on 12-DEC-2008 was inadvertently vaccinated with a dose of VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck).  It was reported that the patient had not experienced any known symptoms.  This is one of two reports from the same source.  Additional information has been requested.
Patient experienced flushing/sweating and near sycnope. BP 113/73, HR60. After patient taken to medical tent, she laid down and given juice. Felt better and felt comfortable leaving after 15 minutes, vitals stable, patient left in stable condition.
Received flu and pneumonia shots on 8/27/2021. Flu-like symptoms developed on 8/28/2021 and lasted seven days (sore throat, fatigue, headaches, body aches, pain behind eyes; no fever, oxygen saturation was fine).  Went for Covid-19 test and tested positive on 9/3/2021.
vomiting and diarrhea, cold sweats for ~15 hrs, then all fine.
Patient came from another country. He was shrieking and had no speech/babbling. He was hyperactive and could not be held. He had to be moving all the time. He had speech delay identified at 2 years old. He had auditory processing found at age 7. He had sensory processing disorder found at age 3. He has hypermobility. He had many allergies and had a tonsillectomy at 3 years. He had OCD. He was finally diagnosed with autism with psychiatry at age 17. He has anxiety and ADHD. His IQ tests in the lower 30%. His expressive speech is still delayed.
light headedness,fever, racing heart,sob,chest pain,neck pain, nausea as reported to pharmacy by patients mother
Feeling Achy; developed a cough; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Feeling Achy) and COUGH (developed a cough) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 15-Apr-2021, the patient experienced PAIN (Feeling Achy) and COUGH (developed a cough). The patient was treated with IBUPROFEN at a dose of UNK dosage form. At the time of the report, PAIN (Feeling Achy) and COUGH (developed a cough) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
anaphylaxis; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for six patients. This is the second of six reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: AK 5730, EG 1685), via an unspecified route of administration in Dec2020 at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced anaphylaxis in Dec2020.  The clinical outcome of anaphylaxis was unknown.    No follow-up attempts are possible.  No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020505820 different patient/same drug/event
Developed tinnitus in both ears 2-3 weeks after vaccine. No treatment available; still have tinnitus a year later.
Pt developed a fine, papular rash on face and trunk and a fever as per phone call on 7/14/01. Follow-up on 7/17/01 indicated rash and other symptoms improving.
First shot: Small nickel sized rash on right wrist. Itchy with red bumps for the first two weeks. Second two weeks, the rash faded, but it still looked like eczema.  Second shot:  - Pins and needles tingling feeling in left hand and wrist. Began immediately after the shot and lasted 3-4 hours. - Rash around the site of the inspection that appeared the second day and last for about 4 days. A rash appeared on arms on the third day and only lasted that day. - Nickel sized rash that was healing (from first shot) flared again with red bumps, itching. The bumps are gone, but it is still red, itches, and has eczema appearance.
pt recv 3 doses of vax & hep b surface antigen (HBsAg) was non reactive, & hepatitis B core antibody was positive;
2/18/2021 injection site started to get itchy, 2/19/2021 little itchy still, a red circle  of about 1 inch  circumference of injection site appeared is also a firm bump, 2/20-21/2021 red circle of about 1 inch circumference of injection site and firm bump remains, 2/22/2021 bump is not as firm but slightly warm to the touch and still a red circle of about 1 inch circumference of injection site  Have not taken any medications
Extreme left arm ache,  chills and low grade fever, headache, overall  severe body aches, fatigue.  Lasted about 24 hours then just arm ache.
I had a bad side effect and have been advised not to take the second; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (I had a bad side effect and have been advised not to take the second) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (I had a bad side effect and have been advised not to take the second). At the time of the report, ADVERSE REACTION (I had a bad side effect and have been advised not to take the second) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
This spontaneous report was received from a nurse referring to unknown number of patients of unknown age and gender. No information about patients' medical history, concurrent conditions and concomitant medications was reported. On an unknown date on of after 05-APR-2016, the patients were vaccinated with improperly stored doses of GARDASIL which had Lot # K008931, expiry date: 04-MAR-2016 (dose and route not reported). The vaccine was exposed to temperature of 34 degree Fahrenheit for 3 hours. No previous temperature excursion was reported. The temperature excursions were detected by a data logger. Additionally, no adverse effects were reported and no product quality complaint (PQC) was involved. Additional information has been requested.
On 5/14/15 child received MMR #1 and VARIVAX #1 and Hep #1. Child presented to the Emergency room with a fever of 104 and an apparent febrile seizure.
High blood pressure, 217/122. Pulse 132 strong pain in the neck, Palpitations, on the second day fever, chills, weakness and pain in the arm and swelling and dizziness.
HPV 1st dose given on 09/07/2007, 2nd dose given on 12/15/2014, and 3rd dose given on 02/23/2015. Provider requested pt be given 3rd dose.
Patient first described a rash developing on arm of injection site. The next day, on 5/31/17, patient noticed arm began to feel stiff and more redness occurred. Patient came to pharmacy on 6/1/17 to report symptoms. Pharmacist encouraged patient to report symptoms to primary care physician to make them aware. In addition, pharmacist explained that rash was common, however patient believed redness and stiffness on arm to be a hematoma, which is a more rare side effect. Pharmacist counseled to use Hydrocortisone cream to assist with itching and to keep an eye out to see if any improvement. If no improvement occurs, stated to contact pharmacy and physician once more.
loud tinnitus in both ears.  treated with steroids, no improvements.  no improvement as of today 5/12/2021
Caller received both covid vaccines. She is still covid positive; Caller received both covid vaccines. She is still covid positive; This is a spontaneous report from a contactable consumer or other non hcp (patient) via a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single dose for Covid-19 immunization. The patient medical history and concomitant medications were not reported.  The patient received first dose of bnt162b2, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) for covid-19 immunization. The patient reported that she had received both covid vaccines. She was still covid positive. The patient underwent lab test and procedures which included Sars-cov-2 test which showed covid Positive. The case was assessed as medically significant. The outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Pt has scattered lesions on extremities and trunk. Intense diaper rash with lesions. Fever up to 101 F.
Redness, swelling, warmth, tenderness onset 7-29-09 applied warm compress TYLENOL given - tenderness, warmth.  Worsened 7-30-09 gave BENADRYL 20mg three times a day.
Extensive rash/hives developed across face Saturday evening (9 October), preceded by fever of around 104.  Patient seen by prescriber, who ruled out strep and Covid virus with negative tests.  Unknown resolution.  Patient fill history shows mupirocin ointment prescribed 11 October, cephalexin prescribed 12 October.
Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; Second day, fever continues with muscle/body pain.; Second day, fever continues with muscle/body pain.; Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; pain at site of injection; slight headache at top portion of head; extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via unspecified route of administration in the left arm on 31Mar2021 at 10:30 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. The patient medical history included fibromyalgia and rheumatoid arthritis. The patient had received concomitant medications within two weeks included duloxetine hydrochloride (CYMBALTA) 60 miligrams and meloxicam (MOBIC), from unknown dates for unknown indications. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 14:00, the patient initially had pain at site of injection, slight headache at top portion of head, extreme fatigue. On 01Apr2021 (next day past noon), continued fatigue with sweating and chills, followed by fever highest of 102.3 (unspecified unit) that started at 20:00. On 01Apr2021, second day, fever continued with muscle and body pain. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vaccination site pain, headache, fatigue, sweating, fever, muscle pain and body pain were resolving at the time of this report  No follow-up attempts are needed. No further information is expected.
Scratchy throat, "tingly mouth/lips", lips swelling. Treated with BENADRYL for two days (given by parent).
Rubella vaccine given on 3/29/01. Pt went to ER on 4/14/01 with a complaint of rash and itching.
Initial report received from a healthcare professional  on 17 OCTOBER 2013.  A 9-year-old female patient had received a dose of FLUZONE (batch number: UA780AA, dose number was not reported) intramuscularly in deltoid on 24 OCTOBER 2013. The patient had no illness at time of vaccination. The patient had medical history of asthma, rhinitis and allergy to Singulair and concomitant medications was not report4ed. On 15 OCTOBER 2013, one day of vaccination, the patient developed redness and itching at injection site. Laboratory tests and corrective treatments were not reported. At the time of this report the outcome was unknown. List of documents held by sender: None.   Follow-up information received from a healthcare professional on 20 JANUARY 2014. On an unspecified date, the patient had recovered from the event. The physicians address was updated. The patient had not received any other vaccine.
After receiving each does of the vaccine, first on 8/26/21 and second on 9/16/21, the next morning about 21 hours after each shot I experienced chest pains and difficulty breathing. Both days this lasted for about 60 to 90 minutes.
Acid reflux; Arms started feeling achy; Random chills; Headache; Mild nausea in the morning; Fatigue; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux), PAIN IN EXTREMITY (Arms started feeling achy), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (Mild nausea in the morning) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gastric irritation, Hypothyroidism and Allergy. Concurrent medical conditions included Hypertension. Concomitant products included FAMOTIDINE, NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), LEVOTHYROXINE SODIUM (SYNTHROID) and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain). On 18-Jan-2021, the patient experienced FATIGUE (Fatigue). On 19-Jan-2021, the patient experienced HEADACHE (Headache) and NAUSEA (Mild nausea in the morning). On 20-Jan-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux), PAIN IN EXTREMITY (Arms started feeling achy) and CHILLS (Random chills). On 16-Jan-2021, VACCINATION SITE PAIN (Injection site pain) had resolved. At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux), PAIN IN EXTREMITY (Arms started feeling achy), FATIGUE (Fatigue), HEADACHE (Headache), NAUSEA (Mild nausea in the morning) and CHILLS (Random chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication detail was reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: The follow up document contain no new information.
I was diagnosed with mono on May 8. Unclear if there is a connection but unusual given social distancing and my age.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 28Mar2021 at 08:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies to food, medicine or other products. The patient did not receive any medication within two weeks prior to vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6121 EN6199) via an unspecified route of administration in the left arm on 07Mar2021 at 08:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was diagnosed with mononucleosis on 08May2021. The patient was unclear if there was a connection but unusual given social distancing and her age. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event. On 08May2021, the patient underwent COVID- 19 test and the result was negative. The clinical outcome of the event diagnosed with mononucleosis on 08May2021, unclear if there was a connection but unusual given social distancing and patients age was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
day after:  bruise, 2 inch red circle, soreness in vaccination area - improved after icing 7 days later:  area itchy, larger red circle/rash, area hard & warm to touch At day 13 - symptoms lessened, but not totally gone Similar symptoms to description of COVID arm
Patient is a 6 mo old male who presents for: 6 month shots last month with his parents. Bump appeared right after shots and has stayed mostly consistent. Bump has maybe gotten a little harder. No other problems and the bump doesn't ever seem to bother him. Haven't tried anything to help get it better. He had small reactions after previous shots but they went away after about a week. No temperatures and no other problems.
Swollen lymph node in armpit in same arm as injection.  My upper back seems a little tight and sore, too.  It's just light pain so far, nothing drastic.  I just thought I should report it.  It just started today, so I don't know how long it will last.
mom called, pt had broken out in a rash on face; 4AUG95 mom states had a few tiny bumps on forehead but nothing else now; broken out in a rash 1AUG95; 4AUG95 mom reached by phone pt still has a few little tiny bumps;
Information has been received from a  physician concerning a female who was vaccinated intramuscularly with a dose of Gardasil.  Subsequently the patient became woozy "almost immediately after vaccination".  Medical attention was not sought.  The patient recovered before leaving the office.  Additional information has been requested.
elevated heart rate; lightheadedness and dizziness which felt like the room was spinning; This spontaneous case was reported by a patient and describes the occurrence of HEART RATE INCREASED (elevated heart rate) and DIZZINESS (lightheadedness and dizziness which felt like the room was spinning) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (elevated heart rate) and DIZZINESS (lightheadedness and dizziness which felt like the room was spinning). At the time of the report, HEART RATE INCREASED (elevated heart rate) and DIZZINESS (lightheadedness and dizziness which felt like the room was spinning) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No relevant concomitant medications were reported.  Treatment information was not provided.
She went to urgent care 7 days after her second Moderna shot for an allergic reaction with red itchy rash all over her body.  Unknown if it was caused by the vaccine.